Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
How-To Geek on MSN
Stop crashing your Python scripts: How Zarr handles massive arrays
Tired of out-of-memory errors derailing your data analysis? There's a better way to handle huge arrays in Python.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback